Crossmark

High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance)

Crossref DOI link: https://doi.org/10.1038/bcj.2017.57

Published Online: 2017-06-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Witzig, T E

LaPlant, B

Habermann, T M

McPhail, E

Inwards, D J

Micallef, I N

Colgan, J P

Nowakowski, G S

Ansell, S M

Johnston, P B
License Information

Text and Data Mining valid from 2017-06-23

Version of Record valid from 2017-06-23
More Information

Article History

First Online: 23 June 2017

Competing interests

: The authors declare no conflict of interest.

Document is current

Any future updates will be listed below